Material Event (Form 8-K)

Item 8.01 Other Events

On November 5, 2025, Aethlon Medical, Inc., a Nevada corporation (the "Company") received a letter from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(2) (the "Minimum Bid Price Requirement") for continued listing on The Nasdaq Capital Market.

As previously disclosed, on October 16, 2025, the Company received a letter from Nasdaq, notifying the Company that it was not in compliance with the Minimum Bid Price Requirement because the Company's common stock, par value $0.001 (the "Common Stock"), had closed below the $1.00 per share minimum for 30 consecutive business days. To regain compliance with the Minimum Bid Price Requirement, the Common Stock was required to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days.

In its letter dated November 5, 2025, Nasdaq indicated the Company has regained compliance with the Minimum Bid Price Requirement, and the matter is now closed.